 Azacitidine , a deoxyribonucleic acid hypomethylating agent , is used in the treatment of myelodysplastic syndrome<symptom>. Common adverse effects of azacitidine include bone<disease> marrow suppression , injection site reactions , nausea<symptom> , vomiting , diarrhea<disease><symptom> , and fatigue<symptom>. This report focuses on pleuropericardial effusions<symptom> , an infrequently reported and potentially reversible adverse effect of azacitidine. In this case report , pleuropericardial effusion<symptom> manifested as the sole radiographic finding in the evaluation of cough<symptom> occurring during the eighth cycle of treatment with azacitidine. Symptoms<symptom> and radiographic abnormalities resolved with corticosteroids and diuretics , and the patient could continue with therapy.